Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease
Prashant Kapoor, Meletios A Dimopoulos, Stephen M. Ansell, Efstathios Kastritis, Ranjana H. Advani, Éric Durot, Pierre Morel, Charalampia Kyriakou, Roman Hájek, Daniela Drandi, Jithma P. Abeykoon, Signy Chow, Xinxin Cao, Christopher J. Patterson, Jeffrey Matous, Christian Buske, Steven P. Treon, Marie José Kersten (2025). Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease. , 62(2), DOI: https://doi.org/10.1053/j.seminhematol.2025.04.001.
Article41 days agoP1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA
Saurabh Zanwar, Jithma P. Abeykoon, Jorge J. Castillo, Éric Durot, Efstathios Kastritis, Encarl Uppal, Pascal Morel, R. Tawfiq, Lydia Montes, Jonas Paludo, Shayna Sarosiek, S. Kumar, Olabisi Ogunbiyi, Pascale Cornillet‐Lefèbvre, Robert A. Kyle, Alain Delmer, Morie A. Gertz, Meletios A Dimopoulos, S. Ansell, Steven Treon, Sapna D'Sa, Prashant Kapoor (2022). P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA. , 6, DOI: https://doi.org/10.1097/01.hs9.0000847504.29146.b9.
Article41 days agoP-169: Bendamustine rituximab primary therapy for Waldenström Macroglobulinemia: an international, multicenter collaborative study
Saurabh Zanwar, Jithma P. Abeykoon, Jorge J. Castillo, Éric Durot, Efstathios Kastritis, Encarl Uppal, P. Morel, Reema Tawfiq, Lydia Montes, Jonas Paludo, Shayna Saroseik, Shaji Kumar, Olabisi Ogunbiyi, Pascale Cornillet‐Lefèbvre, Robert A. Kyle, Alain Delmer, Morie A. Gertz, Meletios A Dimopoulos, Stephen M. Ansell, Steven P. Treon, Shirley D’Sa, Prashant Kapoor (2022). P-169: Bendamustine rituximab primary therapy for Waldenström Macroglobulinemia: an international, multicenter collaborative study. , 22, DOI: https://doi.org/10.1016/s2152-2650(22)00499-2.
Article41 days agoBendamustine rituximab (BR) versus ibrutinib (Ibr) as primary therapy for Waldenström macroglobulinemia (WM): An international collaborative study.
Jithma P. Abeykoon, Shaji Kumar, Jorge J. Castillo, Shirley D’Sa, Efstathios Kastritis, Éric Durot, Encarl Uppal, Pierre Morel, Jonas Paludo, Reema Tawfiq, Shayna Sarosiek, Olabisi Ogunbiyi, Pascale Cornillet‐Lefèbvre, Robert A. Kyle, Alain Delmer, Morie A. Gertz, Meletios A Dimopoulos, Steven P. Treon, Stephen M. Ansell, Prashant Kapoor (2022). Bendamustine rituximab (BR) versus ibrutinib (Ibr) as primary therapy for Waldenström macroglobulinemia (WM): An international collaborative study.. , 40(16_suppl), DOI: https://doi.org/10.1200/jco.2022.40.16_suppl.7566.
Article41 days agoHigh frequency of central nervous system involvement in transformed Waldenström macroglobulinemia
Éric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, Elise Toussaint, Efstathios Kastritis, Shirley D’Sa, Miguel Alcoceba, Cécile Tomowiak, Bénédicte Hivert, Caroline Protin, Jithma P. Abeykoon, Josephine M. I. Vos, Anne‐Sophie Michallet, Cyrielle Rodier, Jehan Dupuis, Stéphane Leprêtre, Fatiha Merabet, Xavier Roussel, Jean‐Marc Zini, Caroline Régny, Aisha S Patel, Pierre Morel, Damien Roos‐Weil, Steven P. Treon, Meletios A Dimopoulos, Ramón García‐Sánz, Prashant Kapoor, Jorge J. Castillo, Alain Delmer (2022). High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia. , 6(12), DOI: https://doi.org/10.1182/bloodadvances.2022007331.
Article41 days ago